FDA finds deficiencies in Mylan's generic Advair

June 13 (Reuters) - U.S. drugmaker Mylan NV said on Wednesday that U.S. health regulators could not approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug, Advair, and cited "minor deficiencies" with the copycat version.

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

Jamal Khashoggi: Saudis blame 'rogues' as pressure on crown prince grows

Corker: US intercepts ‘point to involvement at a very high level’Trump ‘would love’ if Mohammed bin Salman not responsibleA senior Republican senator on Sunday said he believed the Saudi crown prince was responsible for the killing of Jamal Khashoggi and...

0 0

At least 14 killed in violence in eastern Congo's Ebola zone

Unidentified gunmen killed at least 14 people, including two health workers, on Saturday in an area of eastern Democratic Republic of Congo where militia violence has hampered efforts to contain an Ebola outbreak, authorities said.

0 0

Tennis: First ATP title for Britain's Edmund

British number one Kyle Edmund won the first ATP title of his career when he beat Gael Monfils of France 3-6 7-6(2) 7-6(4) in the final of the European Open in Antwerp on Sunday.

0 0

Bombardier sues Mitsubishi jet program over trade secrets

Canadian airplane maker Bombardier Inc has sued the aircraft unit of Japan's Mitsubishi Heavy Industries Ltd, saying former Bombardier employees passed on trade secrets to help Mitsubishi's oft-delayed regional jet project.

0 0

Bombardier sues Mitsubishi jet program over trade secrets

Canadian airplane maker Bombardier Inc has sued the aircraft unit of Japan's Mitsubishi Heavy Industries Ltd , saying former Bombardier employees passed on trade secrets to help Mitsubishi's oft-delayed regional jet project.

0 0

Whoops, looks like something went wrong.